Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
Clinical trial NCT02959905 · COMPLETED
Trial details
- NCT number
- NCT02959905
- Sponsor
- BGI, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2020-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.